NCT06552000View on ClinicalTrials.gov

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2029

Conditions
NSCLCNon Small Cell Lung Cancer
Interventions
DEVICE

NovoTTF-200T System

Exposure/Frequency: 150 kHz Route: Transdermal through patented microarray system to the hemithorax affected with cancer, 2-4 week duration, target 18 hours/day (on average)

Trial Locations (1)

75390

The University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER